1. Biometric & Lab Screenings
Debunking the myths to unlock the power of Total Population Health Management

2. Hooper Holmes Health & Wellness
New division of 109 year old health information company
9,000+ examiners
CLIA/CAP/NGSP certified laboratory
FDA approved medical device manufacturer
50,000 sq foot warehouse and shipping facility
Provide services exclusively to health & care management companies
Do not market to, or contract with, employers
Private labeled screening solution (the “Intel Inside”)
Screen groups and individuals in a variety of ways
Screen both individuals and groups of all sizes
Venipucture, Cholestech, self-collection kits
2008 accomplishments
200,000 health & wellness screenings completed
4,000+ screening events in over 1,700 cities in all fifty states, DC & PR
99.6% participant satisfaction
Hooper Holmes Confidential

3. Agenda I. Role of Screenings in Total Population Health Page 4
Debunking Common Screening Myths Page 8
III. Enabling Total Population Health Management Page 14
Hooper Holmes Confidential

4. The move to total population health management
Care Management is moving to the left
Well
At Risk
Ill
Chronically
Ill
Acutely
Ill
150+ Million Covered Lives
80%
of population
20%
of population
Managing Costs
Reversing the Trend
Hooper Holmes Confidential

5. Biometric & lab data is a key enabler
Tomorrow’s Cost
Today’s Cost
Well
At Risk
Ill
Chronically
Ill
Acutely
Ill
Claims Data
Biometric & Lab Data
Hooper Holmes Confidential

6. The importance of lab and biometric data
Claims data is too late
Participant is already ill
Good for cost management, not cost avoidance
Can’t help reverse the trend
HRA data alone is not enough
74% of respondents don’t know their biometric or lab data
Only reinforces what the participant knows
Lab and biometric data fills in the gaps
Data on those that you have no data on
Objective data that uncovers unknown risks
Provides a baseline and the data necessary to address the trend
Hooper Holmes Confidential

7. Agenda I. Role of Screenings in Total Population Health Page 4
Debunking Common Screening Myths Page 8
III. Unlocking Total Population Health Management Page 14
Hooper Holmes Confidential

8. SCREENING MYTH #1: Health fairs work
Origins of the myth
Consumers don’t know what’s possible or available
Historical disconnect between health & care mgmt.
Historical lack of programs to act upon the data
Screenings viewed only as an employee benefit
Screenings viewed as a “product”
Debunking the myth
Stand alone health fairs can’t pass the ROI test
The real value of screenings is the data collected
Ongoing engagement outperforms “teachable moment”
Screenings are the front-end to other products
Hooper Holmes Confidential

9. Screenings aren’t an “event” but the start of a “process”
Debunking the myth
Uncover
Risks
Stratify
Pop
Target
Programs
Biometric
Screenings
Establish
Baseline
Measure
ROI
Engage
Particip.
Motivate
Change
Screenings aren’t an “event” but the start of a “process”
Hooper Holmes Confidential

10. SCREENING MYTH #2: incentive = participation = engagement
Origins of the myth
DMAA study shows that providers see better incentives as having the greatest impact on program success
Poor engagement strategies have been combated with higher incentives to increase participation
Incentives viewed as a stand-alone program component
Debunking the myth
Employers see better identification of at-risk participants as having the greatest impact on program success
All parties agree that engagement is key to success
Incentives that are linked to coverage and program design can drive participation and engagement
Hooper Holmes Confidential

11. HRA & screening = incentive
Debunking the myth
What to incent
HRA & screening = incentive
HRA & screening & doing something about it = incentive
How to incent
Incentive = cash or cash equivalent
Incentive = plan feature generating cost shifting
Warning: Incentive and program cannot become adversarial to participants!
Hooper Holmes Confidential

12. SCREENING MYTH #3: Operational misunderstandings
Operational Myths
Fingerstick is cheaper than venipuncture with lab testing
Screening “stations” are more efficient
You can’t efficiently reach remote individuals
Debunking the myths
A Cholestech cassette & full lab panel both cost $10
Stations are championed by providers who don’t have enough phlebotomists or Cholestech machines
Individuals can be screened in home or office or with self-collection kits – without breaking the bank
Hooper Holmes Confidential

13. Agenda I. Role of Screenings in Total Population Health Page 4
Debunking Common Screening Myths Page 8
III. Unlocking Total Population Health Management Page 14
Hooper Holmes Confidential

14. Redefining the role of biometric screenings
Screenings are not:
A product
An event
Simply an employee benefit
Screenings are:
A “feeder” for other products
The beginning of an engagement process
A powerful source of data
Hooper Holmes Confidential

15. Integrating health & care management
Data integration
Lab & biometric data with claims & pharmacy data
Use screening data to establish a baseline to demonstrate future ROI of health management
Product integration
Screenings “feed” disease management
Screenings as the front-end to intervention programs
Incentive integration
Incent action - not just participation
Integrated incentive to shift costs
Hooper Holmes Confidential

16. Role of screenings in total population health
Data +
Claims & Rx
Data
Participant
Engagement
Incentive
ROI
(2nd time around) =
Stratified
Population
Targeted
Programs
Hooper Holmes Confidential